150 related articles for article (PubMed ID: 29853945)
1. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease.
Lewis JE; Atlas SE; Higuera OL; Fiallo A; Rasul A; Farooqi A; Kromo O; Lantigua LA; Tiozzo E; Woolger JM; Goldberg S; Mendez A; Rodriguez AE; Konefal J
Evid Based Complement Alternat Med; 2018; 2018():1751583. PubMed ID: 29853945
[TBL] [Abstract][Full Text] [Related]
2. The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind, Placebo-Control Trial.
Lewis JE; Atlas Bsn SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2020; 17(4):429-441. PubMed ID: 31146613
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED ARTICLE: The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind Placebo-Control Trial.
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2021; 18(2):I-XIII. PubMed ID: 30346850
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Gao J; Higuera OL; Fiallo A; Harvey PD; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Clin Transl Res; 2020 Apr; 5(3):140-147. PubMed ID: 32637718
[TBL] [Abstract][Full Text] [Related]
5. Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study.
Ooi SL; Micalos PS; Zielinski R; Pak SC
Cureus; 2024 Jan; 16(1):e53188. PubMed ID: 38425632
[TBL] [Abstract][Full Text] [Related]
6. The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.
Ooi SL; Pak SC; Micalos PS; Schupfer E; Lockley C; Park MH; Hwang SJ
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925340
[TBL] [Abstract][Full Text] [Related]
7. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
[TBL] [Abstract][Full Text] [Related]
8. Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.
Ooi SL; Micalos PS; Kim J; Pak SC
Pharm Biol; 2024 Dec; 62(1):367-393. PubMed ID: 38745507
[TBL] [Abstract][Full Text] [Related]
9. Modified Rice Bran Arabinoxylan by
Ooi SL; Micalos PS; Pak SC
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687141
[TBL] [Abstract][Full Text] [Related]
10. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Rahimlou M; Yari Z; Hekmatdoost A; Alavian SM; Keshavarz SA
Hepat Mon; 2016 Jan; 16(1):e34897. PubMed ID: 27110262
[TBL] [Abstract][Full Text] [Related]
11. Modified rice bran arabinoxylan as a nutraceutical in health and disease-A scoping review with bibliometric analysis.
Ooi SL; Micalos PS; Pak SC
PLoS One; 2023; 18(8):e0290314. PubMed ID: 37651416
[TBL] [Abstract][Full Text] [Related]
12. Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
Asghari S; Rafraf M; Farzin L; Asghari-Jafarabadi M; Ghavami SM; Somi MH
Adv Pharm Bull; 2018 Jun; 8(2):307-317. PubMed ID: 30023333
[No Abstract] [Full Text] [Related]
13. The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.
Pezeshki A; Safi S; Feizi A; Askari G; Karami F
Int J Prev Med; 2016; 7():28. PubMed ID: 26955458
[TBL] [Abstract][Full Text] [Related]
14. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Ratziu V; Harrison SA; Francque S; Bedossa P; Lehert P; Serfaty L; Romero-Gomez M; Boursier J; Abdelmalek M; Caldwell S; Drenth J; Anstee QM; Hum D; Hanf R; Roudot A; Megnien S; Staels B; Sanyal A;
Gastroenterology; 2016 May; 150(5):1147-1159.e5. PubMed ID: 26874076
[TBL] [Abstract][Full Text] [Related]
15. Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial.
Ooi SL; Pak SC; Micalos PS; Schupfer E; Zielinski R; Jeffries T; Harris G; Golombick T; McKinnon D
Contemp Clin Trials Commun; 2020 Sep; 19():100580. PubMed ID: 32548333
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
[TBL] [Abstract][Full Text] [Related]
17. RBAC and Its Role with the Immune System.
Pescatore F; Prestano C; Kichikova M
Altern Ther Health Med; 2022 Jan; 28(1):8-10. PubMed ID: 35120333
[TBL] [Abstract][Full Text] [Related]
18. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
[TBL] [Abstract][Full Text] [Related]
19. A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.
Kobyliak N; Abenavoli L; Mykhalchyshyn G; Kononenko L; Boccuto L; Kyriienko D; Dynnyk O
J Gastrointestin Liver Dis; 2018 Mar; 27(1):41-49. PubMed ID: 29557414
[TBL] [Abstract][Full Text] [Related]
20. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
